The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease
暂无分享,去创建一个
[1] Z. Werb,et al. Degradation of connective tissue matrices by macrophages. II. Influence of matrix composition on proteolysis of glycoproteins, elastin, and collagen by macrophages in culture , 1980, The Journal of experimental medicine.
[2] R. Mecham,et al. Chemotactic activity of elastin-derived peptides. , 1980, The Journal of clinical investigation.
[3] R. Rosenberg,et al. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells , 1985, The Journal of cell biology.
[4] V. Muzykantov,et al. Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics. , 1985, Collagen and related research.
[5] P. Bornstein,et al. Light microscopic immunolocation of thrombospondin in human tissues. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[7] B. Voss,et al. Localization of collagen types I, III, IV and V, fibronectin and laminin in human arteries by the indirect immunofluorescence method. , 1986, Pathology, research and practice.
[8] M. Jacob,et al. Effect of elastin peptides on human monocytes: Ca2+ mobilization, stimulation of respiratory burst and enzyme secretion. , 1986, Biochemical and biophysical research communications.
[9] J. Thyberg,et al. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.
[10] V. Velebný,et al. Biological effects of elastin peptides. , 1988, Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove.
[11] E. Ruoslahti. Fibronectin and its receptors. , 1988, Annual review of biochemistry.
[12] R. Clark,et al. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. , 1988, The Journal of biological chemistry.
[13] J. Thyberg,et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.
[14] J. Schittny,et al. Molecular architecture of basement membranes , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[16] J. Schwarzbauer. Fibronectin: from gene to protein. , 1991, Current opinion in cell biology.
[17] P. Bornstein,et al. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.
[18] U. Hedin,et al. Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. , 1991, The American journal of pathology.
[19] S. Haskill,et al. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] Y Okada,et al. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[21] T. Wight,et al. The role of proteoglycans in cell adhesion, migration and proliferation , 1992, Current Biology.
[22] R. Ross,et al. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Beezhold,et al. Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes , 1992, Journal of leukocyte biology.
[24] E. Dejana,et al. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. , 1992, Blood.
[25] A. Colombatti,et al. Emilin, a component of elastic fibers preferentially located at the elastin-microfibrils interface , 1993, The Journal of cell biology.
[26] J. Rosenbloom,et al. Extracellular matrix 4: The elastic fiber , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[28] M. Schwartz,et al. The extracellular matrix as a cell survival factor. , 1993, Molecular biology of the cell.
[29] C. Alpers,et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.
[30] L. Water,et al. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. , 1994, Molecular biology of the cell.
[31] R. Ross,et al. Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. , 1994, The American journal of pathology.
[32] M. Jaye,et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.
[33] R. Timpl,et al. The laminins. , 1994, Matrix biology : journal of the International Society for Matrix Biology.
[34] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[35] J. Isner,et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. , 1994, The American journal of pathology.
[36] M. Reed,et al. Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. , 1995, The American journal of pathology.
[37] P. Bornstein,et al. Diversity of Function Is Inherent in Matricellular Proteins: an Appraisal of Thrombospondin I , 1995 .
[38] R. Savani,et al. The role of hyaluronan and its receptors in restenosis after balloon angioplasty: development of a potential therapy. , 1995, International journal of tissue reactions.
[39] D J Prockop,et al. Collagens: molecular biology, diseases, and potentials for therapy. , 1995, Annual review of biochemistry.
[40] M. Tzardi,et al. Immunohistochemical detection of fibronectin in early and advanced atherosclerosis. , 1995, In vivo.
[41] R. Ross,et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. , 1995, The Journal of clinical investigation.
[42] E. Anggard,et al. Hyaluronan (HYAL-BV 5200) inhibits neo-intimal macrophage influx after balloon-catheter induced injury in the cholesterol-fed rabbit. , 1995, Atherosclerosis.
[43] R. Jaenisch,et al. Type I collagen‐deficient Mov‐13 mice do not retain SPARC in the extracellular matrix: Implications for fibroblast function , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.
[44] D. Sheppard,et al. Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin* , 1996, The Journal of Biological Chemistry.
[45] S. Shapiro,et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. Iozzo,et al. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] M. Ferguson,et al. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. , 1996, The American journal of pathology.
[48] M. Reidy,et al. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. , 1996, Circulation research.
[49] A. Clowes,et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. , 1996, Circulation research.
[50] M. Burdick,et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. , 1996, The Journal of clinical investigation.
[51] James M. Roberts,et al. Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.
[52] E. Haber,et al. Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. , 1997, Circulation research.
[53] J. Schlessinger. Direct Binding and Activation of Receptor Tyrosine Kinases by Collagen , 1997, Cell.
[54] M. Horton,et al. Hyaluronan Fragments Induce Nitric-oxide Synthase in Murine Macrophages through a Nuclear Factor κB-dependent Mechanism* , 1997, The Journal of Biological Chemistry.
[55] D. Carey,et al. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[56] J. Fraser,et al. Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.
[57] J. Thyberg,et al. Phenotypic Modulation of Smooth Muscle Cells after Arterial Injury Is Associated with Changes in the Distribution of Laminin and Fibronectin , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[58] C. Shuttleworth. Type VIII collagen. , 1997, The international journal of biochemistry & cell biology.
[59] Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. , 1997, Trends in cell biology.
[60] M. Ginsberg,et al. Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology. , 1997, The Journal of clinical investigation.
[61] T. Wight,et al. Selective Expression and Processing of Biglycan during Migration of Bovine Aortic Endothelial Cells , 1997, The Journal of Biological Chemistry.
[62] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[63] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[64] J. Thyberg,et al. Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture. , 1997, Cardiovascular research.
[65] C. S. Chen,et al. Geometric control of cell life and death. , 1997, Science.
[66] S. Schwartz,et al. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[67] J. Isner,et al. Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries. , 1997, The American journal of pathology.
[68] J. J. Schwartz,et al. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? , 1997, The Journal of clinical investigation.
[69] Jussi Taipale,et al. Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] P. Libby,et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.
[71] R. Ross,et al. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. , 1998, The American journal of pathology.
[72] J. Isner,et al. Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. , 1998, American heart journal.
[73] M. Slepian,et al. β3-Integrins Rather Than β1-Integrins Dominate Integrin-Matrix Interactions Involved in Postinjury Smooth Muscle Cell Migration , 1998 .
[74] N. Fausto,et al. NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival , 1998, The Journal of cell biology.
[75] Dean Y. Li,et al. Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.
[76] K. O. Mercurius,et al. Inhibition of vascular smooth muscle cell growth by inhibition of fibronectin matrix assembly. , 1998, Circulation research.
[77] Masato Kato,et al. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 , 1998, Nature Medicine.
[78] R. Mecham,et al. Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.
[79] Z. Galis,et al. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[80] M. Crow,et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. , 1998, Circulation.
[81] K. Watson,et al. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[82] R. Mecham,et al. Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. , 1998, Circulation research.
[83] S. Kaul,et al. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. , 1999, Circulation.
[84] Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. , 1999, Journal of immunology.
[85] S. Tyagi,et al. Responses of vascular smooth muscle cell to extracellular matrix degradation , 1999, Journal of cellular biochemistry.
[86] G. Neufeld,et al. Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165 * , 1999, The Journal of Biological Chemistry.
[87] J. Isner,et al. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. , 1999, Circulation.
[88] C. Owen,et al. The cell biology of leukocyte‐mediated proteolysis , 1999, Journal of leukocyte biology.
[89] N. Carragher,et al. Degraded Collagen Fragments Promote Rapid Disassembly of Smooth Muscle Focal Adhesions That Correlates with Cleavage of Pp125FAK, Paxillin, and Talin , 1999, The Journal of cell biology.
[90] P. Cullen,et al. Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[91] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[92] A. Clowes,et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. , 1999, Circulation research.
[93] P. Libby,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.
[94] M. Hirose,et al. Restoration to a quiescent and contractile phenotype from a proliferative phenotype of myofibroblast-like human aortic smooth muscle cells by culture on type IV collagen gels. , 1999, Journal of biochemistry.
[95] R. Timpl,et al. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[96] T. Cruz,et al. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. , 1999, Biochemical Society transactions.
[97] M A Konerding,et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.
[98] G. Breithardt,et al. Cholesterol-induced changes of type VIII collagen expression and distribution in carotid arteries of rabbit. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[99] T. Wight,et al. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[100] M. Entman,et al. Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration. , 1999, The Journal of clinical investigation.
[101] H. Baba,et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) modulates the expression of type VIII collagen mRNA in vascular smooth muscle cells and both are codistributed during atherogenesis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[102] M D McKee,et al. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. , 1999, Circulation research.
[103] H. Lijnen,et al. Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. , 1999, Circulation research.
[104] N. Carragher,et al. The Extracellular Matrix Dynamically Regulates Smooth Muscle Cell Responsiveness to PDGF a , 2000, Annals of the New York Academy of Sciences.
[105] J. Pickering,et al. α5β1 Integrin Expression and Luminal Edge Fibronectin Matrix Assembly by Smooth Muscle Cells after Arterial Injury , 2000 .
[106] Peter C. Brooks,et al. New Functions for Non-collagenous Domains of Human Collagen Type IV , 2000, The Journal of Biological Chemistry.
[107] G. Hou,et al. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. , 2000, The American journal of pathology.
[108] C. Shanahan,et al. Vascular Extracellular Matrix , 2002 .